Total Payments
$1,155
2024 Payments
$239.39
Companies
27
Transactions
67
Medicare Patients
6,801
Medicare Billing
$623,697
Payment Breakdown by Category
Food & Beverage$1,155 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,155 | 67 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $207.06 | 15 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $121.72 | 1 | $0 (2017) |
| Corcept Therapeutics | $117.37 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $89.02 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $57.78 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $54.62 | 4 | $0 (2024) |
| Novo Nordisk Inc | $51.16 | 4 | $0 (2021) |
| Lilly USA, LLC | $49.93 | 3 | $0 (2022) |
| Allergan, Inc. | $43.30 | 3 | $0 (2020) |
| Almatica Pharma LLC | $42.20 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $239.39 | 10 | Corcept Therapeutics ($117.37) |
| 2023 | $242.16 | 16 | GlaxoSmithKline, LLC. ($182.29) |
| 2022 | $113.53 | 8 | Almatica Pharma LLC ($42.20) |
| 2021 | $78.13 | 6 | AbbVie Inc. ($24.68) |
| 2020 | $26.21 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($13.54) |
| 2019 | $24.28 | 2 | Novo Nordisk Inc ($13.35) |
| 2018 | $126.22 | 10 | Novo Nordisk Inc ($25.59) |
| 2017 | $305.04 | 13 | Regeneron Healthcare Solutions, Inc. ($121.72) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $87.06 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Endocrinology | ||||||
| 06/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Neuroscience | ||||||
| 11/20/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: INSOMNIA | ||||||
| 08/16/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: RESPIRATORY | ||||||
| 08/04/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,132 | 3,412 | $621,400 | $181,085 |
| 2022 | 18 | 1,427 | 1,974 | $405,848 | $93,832 |
| 2021 | 22 | 1,662 | 2,340 | $437,812 | $195,251 |
| 2020 | 22 | 1,580 | 2,143 | $385,000 | $153,529 |
Total Patients
6,801
Total Services
9,869
Medicare Billing
$623,697
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 705 | $194,625 | $37,918 | 19.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 132 | 611 | $76,333 | $36,118 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 319 | 319 | $89,615 | $19,763 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 361 | $70,479 | $16,546 | 23.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 97 | 101 | $27,954 | $15,404 | 55.1% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 75 | 163 | $24,076 | $9,001 | 37.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 307 | 307 | $12,613 | $6,389 | 50.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 51 | 179 | $13,894 | $5,794 | 41.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 42 | 58 | $9,933 | $5,224 | 52.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 53 | 53 | $4,161 | $4,018 | 96.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 23 | 23 | $8,334 | $3,899 | 46.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 193 | 195 | $34,379 | $3,048 | 8.9% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 23 | 23 | $5,055 | $2,792 | 55.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 22 | 22 | $4,208 | $2,441 | 58.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 24 | $13,402 | $2,050 | 15.3% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 36 | 49 | $4,526 | $1,987 | 43.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 67 | 68 | $3,763 | $1,886 | 50.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $2,385 | $1,800 | 75.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 20 | $8,797 | $1,777 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 24 | $9,177 | $1,585 | 17.3% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $1,470 | $764.26 | 52.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 12 | $1,261 | $506.88 | 40.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 31 | $960.76 | $377.12 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 510 | $146,621 | $27,408 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 408 | $83,223 | $18,510 | 22.2% |
About Dr. Krithika Mullengada, MD
Dr. Krithika Mullengada, MD is a Internal Medicine healthcare provider based in Succasunna, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992785562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krithika Mullengada, MD has received a total of $1,155 in payments from pharmaceutical and medical device companies, with $239.39 received in 2024. These payments were reported across 67 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,155).
As a Medicare-enrolled provider, Mullengada has provided services to 6,801 Medicare beneficiaries, totaling 9,869 services with total Medicare billing of $623,697. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Succasunna, NJ
- Active Since 01/19/2006
- Last Updated 09/03/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992785562
Products in Payments
- AREXVY (Drug) $165.95
- PRALUENT ALIROCUMAB INJECTION (Biological) $121.72
- Korlym (Drug) $117.37
- XIFAXAN (Drug) $78.09
- Ozempic (Drug) $38.06
- TRULICITY (Drug) $36.21
- REXULTI (Drug) $33.68
- BYSTOLIC (Drug) $30.63
- Dexcom G6 Transmitter (Medical Supply) $28.12
- TRELEGY ELLIPTA (Drug) $27.51
- NUPLAZID (Drug) $25.39
- LYRICA (Drug) $25.07
- TOUJEO (Drug) $23.91
- UBRELVY (Drug) $23.73
- INVOKANA (Drug) $23.57
- Cologuard Collection Kit (Device) $22.99
- Kerendia (Drug) $20.84
- Senza (Device) $20.80
- QUVIVIQ (Drug) $16.75
- SYMBICORT (Drug) $16.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.